These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 9923973

  • 1. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
    Chen G, Teicher BA, Frei E.
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973
    [Abstract] [Full Text] [Related]

  • 2. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N, Chen J, Yoshida A.
    Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
    Teicher BA, Ikebe M, Ara G, Keyes SR, Herbst RS.
    In Vivo; 1997 Jun; 11(6):463-72. PubMed ID: 9509296
    [Abstract] [Full Text] [Related]

  • 4. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
    Massaad L, de Waziers I, Ribrag V, Janot F, Beaune PH, Morizet J, Gouyette A, Chabot GG.
    Cancer Res; 1992 Dec 01; 52(23):6567-75. PubMed ID: 1423302
    [Abstract] [Full Text] [Related]

  • 5. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB, Zhang Y, Frenkel GD.
    Anticancer Res; 1998 Dec 01; 18(4C):3021-5. PubMed ID: 9713503
    [Abstract] [Full Text] [Related]

  • 6. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
    Tanner B, Hengstler JG, Dietrich B, Henrich M, Steinberg P, Weikel W, Meinert R, Kaina B, Oesch F, Knapstein PG.
    Gynecol Oncol; 1997 Apr 01; 65(1):54-62. PubMed ID: 9103391
    [Abstract] [Full Text] [Related]

  • 7. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 8. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS.
    J Am Coll Surg; 2004 Sep 01; 199(3):419-27. PubMed ID: 15325612
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X, Zhang J, Xu T.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):88-95. PubMed ID: 17156807
    [Abstract] [Full Text] [Related]

  • 10. [Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors].
    Massaad L, de Waziers I, Ribrag V, Janot F, Morizet J, Beaune PH, Gouyette A, Chabot GG.
    Bull Cancer; 1993 May 01; 80(5):397-407. PubMed ID: 8173193
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW.
    Cancer Res; 1992 Oct 01; 52(19):5373-8. PubMed ID: 1356617
    [Abstract] [Full Text] [Related]

  • 12. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, Battaglia R, Howard M, D'Incalci M, Broggini M.
    Cancer Res; 2002 Apr 15; 62(8):2332-6. PubMed ID: 11956092
    [Abstract] [Full Text] [Related]

  • 13. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A, Leith MK, McClarty G, Beenken S, Goldenberg GJ, Wright JA.
    Cancer Res; 1988 Apr 01; 48(7):1727-35. PubMed ID: 3127038
    [Abstract] [Full Text] [Related]

  • 14. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM, Pinedo HM, Scheffer PG, Schlüper HM, Erkelens CA, Boven E.
    Gynecol Oncol; 2000 Mar 01; 76(3):362-8. PubMed ID: 10684711
    [Abstract] [Full Text] [Related]

  • 15. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

  • 16. [Biochemical mechanisms of resistance to a new antineoplastic agent amin(cyclopeptidylamin)-S-(-)-malatoplatinum (II) (cycloplatam)].
    Dederer LIu, Lankin VZ, Konovalova AL, Gorbacheva LB.
    Biokhimiia; 1995 Apr 30; 60(4):602-9. PubMed ID: 7779982
    [Abstract] [Full Text] [Related]

  • 17. Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma.
    Lehnert S, Vestergaard J, Batist G, Aloui-Jamali MA.
    Radiat Res; 1994 Aug 30; 139(2):232-9. PubMed ID: 8052700
    [Abstract] [Full Text] [Related]

  • 18. Expression of a rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity.
    Schecter RL, Alaoui-Jamali MA, Woo A, Fahl WE, Batist G.
    Cancer Res; 1993 Oct 15; 53(20):4900-6. PubMed ID: 8402679
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
    Crescimanno M, D'Alessandro N, Armata MG, Toulmond S, Tapiero H.
    Anticancer Res; 1991 Oct 15; 11(2):901-3. PubMed ID: 2064348
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts.
    Greenbaum M, Létourneau S, Assar H, Schecter RL, Batist G, Cournoyer D.
    Cancer Res; 1994 Aug 15; 54(16):4442-7. PubMed ID: 8044793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.